Search Results - Tom Reuvekamp

Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T‐cell therapy by Jort J. van derSchans, Paresh Vishwasrao, Renée Poels, Morgan Antti, Ziyu Wang, Marjolein Quik, Jennemiek vanArkel, Tom Reuvekamp, Niels W. C. J. van deDonk, Maria Themeli, Gert J. Ossenkoppele, Arjan A. van deLoosdrecht, Rebecca Richards, Tuna Mutis

Get full text